Illness	Number of cases
Malignant neoplasm of prostate (C61)	268
Malignant neoplasm of thyroid gland (C73)	149
Thyrotoxicosis hyperthyroidism (E05.2)	59
Thyrotoxicosis hyperthyroidism (E05.0)	58
Malignant neoplasm of pancreas - Malignant neoplasm of pancreas unspecified (C25.9)	32
Thyrotoxicosis hyperthyroidism (E05.1)	22
Malignant neoplasm of small intestine - Malignant neoplasm of ileum (C17.2)	15
Malignant neoplasm of pancreas - Malignant neoplasm of endocrine pancreas (C25.4)	12
Malignant neoplasm of breast (C50.9)	11
Malignant neoplasm of bronchus and lung (C34.0)	8

Top 10 treatments

Treatment	Number
Treatment with radioactive substance taken up by the body (8-530.d0)	271
Treatment with radioactive substance taken up by the body (8-530.61)	156
Investigation of uptake and release by the cells and organs with the aid or radioactive substances (3-70b.2)	139
Radiotherapy of the thyroid gland with radioactive iodine (8-531.00)	135
Radiotherapy of the thyroid gland with radioactive iodine (8-531.11)	77
Radiotherapy of the thyroid gland with radioactive iodine (8-531.01)	62
Transfusion of blood, red blood cells or platelets from a donor to a recipient (8-800.c0)	45
(9-984.7)	34
(9-984.8)	16
(9-984.9)	12

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 3200

Type of specialist department

Non-bedded department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law

Bezeichnung
Teilnahme externe Qualitätssicherung	0
Bezeichnung
Teilnahme externe Qualitätssicherung	0
Bezeichnung
Teilnahme externe Qualitätssicherung	0

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
51	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
51	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
23	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility